Evolution of GCA Treatments - More to Come by Meral El Ramahi ( @MeralElRamahiMD) #ACR20 Reflecting on the innovative treatment approach to Giant Cell Arteritis (GCA) https://t.co/xuQ7Litn8t https://t.co/4NtVSMOPsS

• https://bit.ly/36ohw9z

GCA Treatment Data: Dr. David Liew Abstract ( @drdavidliew) Dr. David Liew reviews abstracts #0516 and #0513 presented at the #ACR20 annual meeting. https://t.co/KmjTRmDbA1

• https://bit.ly/3liEoNG

Read our article titled: Best Imaging Techniques for non ANCA Vasculitis by Dr. Alexa Meara ( @lexmeara) as discussed at #ACR20 https://t.co/kwXUhn8QSG https://t.co/OjTtFE6jEt

• https://bit.ly/35c92Te

Dr P Seo notes based on PEXIVAS study while PLEX does not seem to help with AAV, it showed you can drop steroid dose sooner: start pred 1 mg/kg/d but drop down after 1 week to 0.5 mg/kg/d #ACRReview #ACR20 @rheumnow

And we're off! #ACR20 year in review ⭐️@philseo's #Vasculitis lecture⭐️ Take home lessons/ remaining questions from GiACTA ⬇️ #ACRambassador https://t.co/7C9QxbUeNH

📌More #Vasculitis pearls from #ACR20 Year in Review #PEXIVAS in a nutshell ⬇️ #ACRambassador https://t.co/PnoP7QIiYs

There are a number of important mimics of IgG4-RD that should be considered 🔵ANCA-associated vasculitis 🔵Multicentric Castleman’s disease 🔵Rosai-Dorfman disease 🔵Inflammatory myofibroblastic tumour 🔵Cutaneous plasmacytosis 🔵Erdheim-Chester disease 🔵Malignancy #ACR20